Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
8129 | 1 | PROTEIN FORMULATION//PROTEIN AGGREGATION//SUBVISIBLE PARTICLES | 1312 |
8467 | 1 | AGALACTOSYL IGG//CHRISTIAN DOPPLER ANTIBODY ENGN//EFFECTOR FUNCTION | 1281 |
10180 | 1 | FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION | 1116 |
11000 | 1 | ISOASPARTATE//DEAMIDATION//PROTEIN L ISOASPARTYL METHYLTRANSFERASE | 1045 |
12413 | 1 | ANTIBODY DRUG CONJUGATE//TRASTUZUMAB EMTANSINE//T DM1 | 938 |
12923 | 1 | BIOSIMILAR//CT P13//ANTI ERYTHROPOIETIN ANTIBODIES | 903 |
13194 | 1 | PROT ANALYT CHEM//CE SDS//RECOMBINANT MONOCLONAL ANTIBODY | 885 |
15359 | 1 | ANTI DRUG ANTIBODIES//BIOANALYSIS//LIGAND BINDING ASSAY | 743 |
31800 | 1 | TGN1412//CYTOKINE RELEASE ASSAY//TAB08 | 161 |
38827 | 1 | DCTDA//ADENO ASSOICATED VIRUS//BIOLOGICAL DERIVED MEDICINES | 52 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BIOSIMILAR | authKW | 873323 | 4% | 63% | 369 |
2 | FCRN | authKW | 461771 | 2% | 85% | 145 |
3 | ANTIBODY DRUG CONJUGATE | authKW | 429021 | 3% | 54% | 212 |
4 | MABS | journal | 373624 | 3% | 36% | 282 |
5 | PROTEIN FORMULATION | authKW | 365344 | 2% | 54% | 180 |
6 | PROT ANALYT CHEM | address | 238477 | 1% | 72% | 89 |
7 | NEONATAL FC RECEPTOR | authKW | 231358 | 1% | 85% | 73 |
8 | DEAMIDATION | authKW | 207468 | 2% | 37% | 151 |
9 | ANTI DRUG ANTIBODIES | authKW | 184178 | 1% | 59% | 84 |
10 | LATE STAGE PHARMACEUT DEV | address | 163871 | 1% | 83% | 53 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 16164 | 27% | 0% | 2270 |
2 | Biochemical Research Methods | 14501 | 14% | 0% | 1220 |
3 | Chemistry, Analytical | 7225 | 14% | 0% | 1163 |
4 | Immunology | 4814 | 13% | 0% | 1091 |
5 | Biochemistry & Molecular Biology | 3890 | 21% | 0% | 1801 |
6 | Chemistry, Medicinal | 3406 | 7% | 0% | 561 |
7 | Medicine, Research & Experimental | 2095 | 7% | 0% | 595 |
8 | Chemistry, Multidisciplinary | 1675 | 12% | 0% | 1011 |
9 | Rheumatology | 1639 | 3% | 0% | 239 |
10 | Biotechnology & Applied Microbiology | 1512 | 7% | 0% | 600 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROT ANALYT CHEM | 238477 | 1% | 72% | 89 |
2 | LATE STAGE PHARMACEUT DEV | 163871 | 1% | 83% | 53 |
3 | ANALYT FORMULAT SCI | 104791 | 0% | 70% | 40 |
4 | PROC PROD DEV | 83184 | 1% | 42% | 53 |
5 | EARLY STAGE PHARMACEUT DEV | 81656 | 0% | 63% | 35 |
6 | FORMULAT SCI | 73429 | 1% | 40% | 49 |
7 | FORMULAT ANALYT OURCES | 68207 | 0% | 70% | 26 |
8 | LATE STAGE PHARMACEUT PROC DEV | 66665 | 0% | 71% | 25 |
9 | MACROMOL VACCINE STABILIZAT | 66258 | 0% | 51% | 35 |
10 | ANALYT DEV QUAL CONTROL | 46910 | 0% | 74% | 17 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MABS | 373624 | 3% | 36% | 282 |
2 | BIOANALYSIS | 129096 | 3% | 15% | 225 |
3 | JOURNAL OF PHARMACEUTICAL SCIENCES | 63222 | 5% | 4% | 440 |
4 | AAPS JOURNAL | 58917 | 2% | 11% | 140 |
5 | PHARMACEUTICAL RESEARCH | 23485 | 3% | 3% | 228 |
6 | BIOPHARM INTERNATIONAL | 14776 | 1% | 8% | 47 |
7 | BIODRUGS | 12989 | 1% | 6% | 60 |
8 | BIOLOGICALS | 12090 | 1% | 5% | 68 |
9 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 11731 | 1% | 7% | 44 |
10 | BIOCONJUGATE CHEMISTRY | 9167 | 1% | 2% | 114 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BIOSIMILAR | 873323 | 4% | 63% | 369 | Search BIOSIMILAR | Search BIOSIMILAR |
2 | FCRN | 461771 | 2% | 85% | 145 | Search FCRN | Search FCRN |
3 | ANTIBODY DRUG CONJUGATE | 429021 | 3% | 54% | 212 | Search ANTIBODY+DRUG+CONJUGATE | Search ANTIBODY+DRUG+CONJUGATE |
4 | PROTEIN FORMULATION | 365344 | 2% | 54% | 180 | Search PROTEIN+FORMULATION | Search PROTEIN+FORMULATION |
5 | NEONATAL FC RECEPTOR | 231358 | 1% | 85% | 73 | Search NEONATAL+FC+RECEPTOR | Search NEONATAL+FC+RECEPTOR |
6 | DEAMIDATION | 207468 | 2% | 37% | 151 | Search DEAMIDATION | Search DEAMIDATION |
7 | ANTI DRUG ANTIBODIES | 184178 | 1% | 59% | 84 | Search ANTI+DRUG+ANTIBODIES | Search ANTI+DRUG+ANTIBODIES |
8 | ISOASPARTATE | 143368 | 1% | 80% | 48 | Search ISOASPARTATE | Search ISOASPARTATE |
9 | PROTEIN AGGREGATION | 138353 | 3% | 13% | 289 | Search PROTEIN+AGGREGATION | Search PROTEIN+AGGREGATION |
10 | CT P13 | 131071 | 0% | 95% | 37 | Search CT+P13 | Search CT+P13 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |